Chronic rapamycin treatment impairs β-cell mass and insulin clearance in rats. Chronic rapamycin treatment impairs β-cell mass and insulin clearance in.

Slides:

Advertisements

Similar presentations

Advertisements

Volume 15, Issue 5, Pages (May 2016)

Supplementary Fig. 2 A B ** newly generated ISL1+ motor neurons (%)

Figure 1 Body weight of control and BPA-treated mothers after delivery

The gene encoding TP53INP1 is expressed in pancreatic endocrine cells A, B(A, B) Immunocytofluorescent staining of TP53INP1 (red) and insulin (green) in.

Insulin and glucagon secretion: nondiabetic and diabetic subjects.

Volume 15, Issue 5, Pages (May 2016)

Rachel Truitt et al. BTS 2018;3:

Viability and function of mouse pancreatic cell line.

Glucose-stimulated insulin secretion in virus-infected human islets.

HOMA calculations where glucose is mmol/L and insulin is mU/L

Zhiyu Wang, Nathaniel W. York, Colin G. Nichols, Maria S. Remedi

Fig. 5 Treatment with an OX40 agonist antibody of 3-week-old HBVtgRag−/− mice or mice with chronic HBV disease results in an altered immune response to.

Cyp8b1−/− mice have improved islet insulin secretion and increased islet insulin content but unchanged β-cell mass. Cyp8b1−/− mice have improved islet.

Effect of insulin on hepcidin expression in HepG2 cells.

Comparison of the protective effects of R and S isomers of LA on insulin-stimulated 2-DG uptake. Comparison of the protective effects of R and S isomers.

The development of plasma (p-)C-peptide responses to an intravenous glucose (0.5 g glucose/kg body wt) and glucagon (1 mg) infusion test up to 5–7 years.

Decreased GLP-1 receptor expression in islets after exposure to high glucose. Decreased GLP-1 receptor expression in islets after exposure to high glucose.

1018-NT-β-cell clusters protect mice from STZ-induced diabetes.

Plasma glucose (A) and glucose specific activity (B) during euglycemic clamp experiments. Plasma glucose (A) and glucose specific activity (B) during euglycemic.

Effect of PIs on insulin release by downstream insulin secretogogues.

Effect of the acute administration of benzylamine plus vanadate on oral glucose tolerance test in STZ-induced diabetic rats. Effect of the acute administration.

Time-dependent effects of IL-6 on tyrosine phosphorylation of IRS-1.

Arterial plasma glucose level and peripheral GIR in conscious dogs during the basal (−40 to 0 min) and experimental (0–240 min) periods treated with vehicle.

In the absence of SST, 20 or 30 mmol/L glucose stimulates glucagon release. In the absence of SST, 20 or 30 mmol/L glucose stimulates glucagon release.

Human and mouse islets express MCH and MCHR1.

Glycemia and glucose tolerance of RIP-N mice.

Mean ± SEM concentration of insulin in plasma and CSF and glucose in plasma 30 min after the intraperitoneal administration of DET or NPH insulin at different.

IL-6 inhibits insulin-induced formation of p85/IRS-1 complexes.

Grg3 works with Pdx1 to repress α-cell genes and induce glucose-stimulated insulin secretion. Grg3 works with Pdx1 to repress α-cell genes and induce glucose-stimulated.

Zn2+ and NAD(P)H content in Mafa∆panc and Mafa∆panc;Mafb+/− β-cells.

Measurement of insulin release from islets evoked by glucose, diazoxide, and high K+. Measurement of insulin release from islets evoked by glucose, diazoxide,

Effect of berberine on white adipose tissue mass.

Grg3 is expressed in most β-cells but less frequently in α-cells.

Inhibition of GCS-derived ganglioside biosynthesis results in increased insulin sensitivity in hypothalamic cells. Inhibition of GCS-derived ganglioside.

Somatostatin released by δ-cells exerts a tonic inhibition on glucagon and insulin secretion but is not required for the glucagonostatic effect of glucose.

A-N: Immunofluorescence analysis of Bcl family genes in human islets of Langerhans. A-N: Immunofluorescence analysis of Bcl family genes in human islets.

Inhibition of glucagon-induced glycogenolysis in human primary hepatocytes. Inhibition of glucagon-induced glycogenolysis in human primary hepatocytes.

Insulitis is reduced in CT-treated RIP-LCMV-GP mice.

Fig. 2 HHKO mice exhibit improved glucose tolerance by increasing plasma incretin levels and insulin secretion. HHKO mice exhibit improved glucose tolerance.

GLP-1 and gastrin combination therapy increases pancreatic insulin content (A) and β-cell mass (B) in NOD mice. GLP-1 and gastrin combination therapy increases.

Involvement of PKCα in downregulation of GLP-1 receptor by high glucose in isolated rat islets. Involvement of PKCα in downregulation of GLP-1 receptor.

Chop deletion preserves β-cell function in P58IPK−/− mice.

Supplementation of c-Rel–competent Treg cells reverts exacerbated diabetes in c-Rel−/− NOD mice. Supplementation of c-Rel–competent Treg cells reverts.

ChREBPα increases β-cell mitochondrial activity and ATP production in human islets. ChREBPα increases β-cell mitochondrial activity and ATP production.

Intracerebroventricular (ICV) insulin infusion increases TG secretion.

Effect of anandamide on blood glucose clearance and insulin sensitivity. Effect of anandamide on blood glucose clearance and insulin sensitivity. A: Intraperitoneal.

Glucose stimulates GLP-1 secretion from the perfused rat intestine by a dose- and absorption-dependent manner. Glucose stimulates GLP-1 secretion from.

The lack of effect of denatonium to stimulate insulin release in the absence of extracellular Ca2+ or in the presence of 10 μmol/l nitrendipine. The lack.

Joan Goulley, Ulf Dahl, Nathalie Baeza, Yuji Mishina, Helena Edlund

Npas4 is a stress-induced factor in pancreatic β-cells.

Metformin (Met) reduces membrane-associated TRPA1 levels in rat DRG neurons. Metformin (Met) reduces membrane-associated TRPA1 levels in rat DRG neurons.

An anti-BTC neutralizing antibody and a metalloproteinase inhibitor suppress GLP-1-induced DNA synthesis in INS(832/13) cells. [3H]thymidine incorporation.

Correlation between pancreatic 111In-exendin accumulation and BCM

Glucose-stimulated insulin secretion, plasma glucagon levels, and pancreatic hormone contents. Glucose-stimulated insulin secretion, plasma glucagon levels,

Arterial and hepatic sinusoidal plasma insulin levels in conscious dogs during the basal (−40 to 0 min) and experimental (0–240 min) periods treated with.

PKA inhibitors do not markedly affect the potentiation of glucose-induced insulin release by GLP-1. PKA inhibitors do not markedly affect the potentiation.

Loss of Phb2 in β-cells induces development of diabetes over a 3-week period in β-Phb2−/− mice. Loss of Phb2 in β-cells induces development of diabetes.

RT-PCR quantification of ubiquitination gene transcripts in rat islets exposed to 2.8 or 16.7 mmol/l glucose for 2 h (A) or 24 h (B). RT-PCR quantification.

Comparison of the percentages of ducts in the pancreas containing cells showing positive staining for the different markers between control patients and.

Pioglitazone administration acutely inhibits insulin secretion and increases insulin clearance in Wistar rats. Pioglitazone administration acutely inhibits.

Increased pancreatic insulin content and islet size and protection against HFD- and palmitate-induced cell death in PKCδKN-overexpressing mice. Increased.

Effect of GSK-3 inhibitors on basal and insulin-stimulated glucose uptake in human muscle cells. Effect of GSK-3 inhibitors on basal and insulin-stimulated.

Effects of vinegar (□) and placebo (⧫) on plasma glucose (A–C) and insulin (D–F) responses after a standard meal in control subjects, insulin-resistant.

Effects of PS-341 on apoptosis in orthotopic human pancreatic tumors.

Cytotoxic activity of HER2-lytic hybrid peptide.

EGFR signaling regulates transcription of PDGFRβ gene.

A, cell number was assessed 96 hours after exposure to indicated treatment in indicated cell models. A, cell number was assessed 96 hours after exposure.

Zhiyu Wang, Nathaniel W. York, Colin G. Nichols, Maria S. Remedi

Cumulative mean numbers of confirmed (plasma glucose ≤3

Presentation transcript:

Chronic rapamycin treatment impairs β-cell mass and insulin clearance in rats. Chronic rapamycin treatment impairs β-cell mass and insulin clearance in rats. Rats were treated with rapamycin as described in the legend to Fig. 1. Pancreatic sections were stained with an antibody against insulin for the determination of islet size and β-cell mass as described in the research design and methods section. A: Size distribution of islets expressed as percentage of total islets. n = 10 for each group. B: Pancreatic β-cell mass. n = 6 for each group. C: Plasma C-peptide levels. n = 12. D: Ratio of insulin over C-peptide, a measure of insulin clearance. n = 12 for each group. E: Insulin secretion was determined in MIN6 cells treated with rapamycin (25 nmol/l; white squares) or vehicle (black squares) for 24 h followed by glucose stimulation (10 mmol/l) for various time points. n = 3 independent experiments. *P ≤ 0.05, ***P ≤ 0.001. Vanessa P. Houde et al. Diabetes 2010;59:1338-1348 ©2010 by American Diabetes Association